Nsight Barbara Nelsen on the business of science.

Building a Biotech Hotbed in the Cold North

Published December 31, 2018. Filed under Biomedical, biotech companies, Biotech funding, Business growth, Innovation, Life science, Minnesota Biotech, Minnesota funding, Venture capital

Okay, @gdombal I will concede that Boston is the center of the universe for biopharma/biotech (for now), though I maintain Minnesota still retains its dominance in all… Read more

Minnesota Life Science Companies to Watch – Part 2

Published May 22, 2017. Filed under Biomedical, Business growth, Innovation, Life science, Minnesota funding

Minnesota is known as a leader in medical device and healthcare and its presence in biopharma is growing. Adding to the list of exciting companies… Read more

Flexible Biomanufacturing Solutions for Cell Therapy

Published June 28, 2016. Filed under Biomedical, Cell manufacturing, Cell therapy, Life science

On average, the cost of bringing a biologic therapy to market is $2.8 billion with a timeline of 10 years or more. As the biologics… Read more

You can’t have a rich biotech ecosystem without critical mass

Published August 13, 2014. Filed under Biomedical, Biotech funding, Business growth, Life science, Pharmaceutical

Catching up on Minnesota news in the Star Tribune a few weeks ago, the following headline caught my eye: “Minnesota loses when tech firms head… Read more

Corporate venture capital: Science First.

Published May 13, 2014. Filed under Biomedical, Biotech funding, Business growth, Life science, Medtech, Startup financing, Strategy, Venture capital

I recently spoke with several corporate venture capital investors (CVCs) when I moderated a panel at the 2014 RESI Conference. The discussion gave definition about… Read more

Categories